875 125 AMC Pill: white, oval, 13mm
The pill with imprint 875 125 AMC (White, Oval, 13mm) has been identified as Amoxicillin and Clavulanate Potassium 875 mg / 125 mg and is used for Bacterial Infection, Bronchitis, Aspiration Pneumonia, Bronchiectasis, and Febrile Neutropenia. It belongs to the drug class penicillins/beta-lactamase inhibitors and is not a controlled substance.
Images for 875 125 AMC
Amoxicillin and Clavulanate Potassium
- Imprint
- 875 125 AMC
- Strength
- 875 mg / 125 mg
- Color
- White
- Size
- 13.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Penicillins/beta-lactamase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Lek Pharmaceuticals
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
crospovidone,
ethylcellulose,
hydroxypropyl cellulose,
magnesium stearate,
microcrystalline cellulose,
polysorbate 80,
magnesium silicate,
titanium dioxide,
triethyl citrate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-0832 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 16714-0478 | NorthStar Rx LLC |
| 66685-1001 | Sandoz Inc. |
| 43063-0077 | PDRX Pharmaceuticals Inc. (repackager) |
| 55289-0767 | PDRX Pharmaceuticals Inc. (repackager) |
See also:
More about amoxicillin / clavulanate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (916)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: penicillins/beta-lactamase inhibitors
- En español
Patient resources
Other brands
Augmentin, Amoclan, Augmentin ES-600, Augmentin XR
Professional resources
- Amoxicillin/Clavulanate monograph
- Amoxicillin and Clavulanate Chewable (FDA)
- Amoxicillin and Clavulanate ER Tablets (FDA)
- Amoxicillin and Clavulanate Oral Suspension (FDA)
- Amoxicillin and Clavulanate Tablets (FDA)
Other brands
Augmentin, Amoclan, Augmentin ES-600, Augmentin XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.